NCT02065856View on ClinicalTrials.gov

An Open Trial to Assess the Tolerability of AVANZ® Salsola Immunotherapy

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

December 31, 2014

Conditions
Allergic Rhinoconjunctivitis Due to Salsola Kali Pollen
Interventions
BIOLOGICAL

AVANZ Salsola

AVANZ Salsola

Trial Locations (1)

Unknown

Hospital General Universitario de Alicante, Alicante

All Listed Sponsors
lead

ALK-Abelló A/S

INDUSTRY

NCT02065856 - An Open Trial to Assess the Tolerability of AVANZ® Salsola Immunotherapy | Biotech Hunter | Biotech Hunter